Skip to main content

Archived Comments for: Investigation of HIFU-induced anti-tumor immunity in a murine tumor model

Back to article

  1. HIFU and potential immune response in cancer therapy

    George Suarez, International HIFU Centers

    5 November 2007

    We have been using HIFU in combination with autologous patient's Dendrite cell therapy for advanced prostate cancer with excellent outcomes. There is no doubt that the combination therapy holds great promise for advanced stage desease in prostate cancer, as well as potential other types of cancer. For more information visit

    Competing interests

    I am the Medical Director for the International HIFU Centers.